StemoniX

We make plates of human tissue for custom drug discovery and precision medicine. Our plates can represent any slice of the world's population down to 1 person.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Eden Prairie, MN, US
  • Currency USD
  • Founded April 2014
  • Employees 4

Company Summary

StemoniX enables Human Pre-clinical Testing to allow Pharma to fail early before Clinical Trials. We have developed a rapid, low-cost, and high-volume process for the growth and differentiation of stem cells. This will revolutionize stem-cell based research and drug screening, and personalized medicine. Our products and services enable the testing of drugs on the tissue of individuals, disease groups, and any portion of the world’s population.

Team

  • Co-founder, CEO

    Mayo Clinic Ventures Mentor, UCSD Alumni Board of Directors, Be The match Leadership Council.
    Led multiple new products in nanotechnology, storage and cloud computing. Successes include leading the first global partnership between Samsung and Seagate that created a new chip found in Samsung flash.
    1 of 3 people identified in the world with graduate and professional degrees/certs in nanotechnology, management, M&A and project/program management.

  • Robert Petcavich
    Co-founder of StemoniX

    PhD (Polymer Chemistry Penn St)
    Formed 6 technology companies
    Has taken 3 companies public on Nasdaq
    Over 30 issued patents worldwide and 20 plus pending
    Board of Advisors of the College of Science of Penn State
    PMD/Executive program from the Harvard Business School

  • VP Engineering

    Mr. Peris has enabled breakthrough operational process improvements in Seagate’s “Factory of the Future”, and the Technical Lead and Principal Engineer that developed production lines for Medtronic and Antares Pharma.

  • Chief Medical Officer

    Dr. Khaleghi MD MBA FACEP is Chief Medical Officer of StemoniX, is the Medical Director of the consumer health technology company WellnessFX, Chief Medical Information Officer of the Noble Health System, and published 7 health books including an Amazon best seller. He holds degrees in bioengineering, medicine, and business from UC San Diego, UC Berkeley, and Columbia University.

  • Director of Cell Biology

    • PhD in the development of cell-based assays for high throughput cancer drug discovery.
    • A leader in the use of human-induced pluripotent stem cells for the study of cardiac diseases at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.

Advisors

  • Dr. Adam Engler
    Science Advisory Board Member
    Unconfirmed
    Dr. ShaoChen Chen
    Board Member
    Unconfirmed
    Science Advisory Board Member
  • Science Advisory Board Member
    Dr. Thomas Chung
    Science Advisory Board Member
    Unconfirmed
    Science Advisory Board Member
  • Strategic Advisor
    Board Member

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free